Invertebrates rely on Dicer to cleave viral double-stranded RNA (dsRNA), and Drosophila Dicer-2 distinguishes dsRNA substrates by their termini. Blunt termini promote processive cleavage, while 3′ overhanging termini are cleaved distributively. To understand this discrimination, we used cryo-electron microscopy to solve structures of Drosophila Dicer-2 alone and in complex with blunt dsRNA. Whereas the Platform-PAZ domains have been considered the only Dicer domains that bind dsRNA termini, unexpectedly, we found that the helicase domain is required for binding blunt, but not 3′ overhanging, termini. We further showed that blunt dsRNA is locally unwound and threaded through the helicase domain in an adenosine triphosphate-dependent manner. Our studies reveal a previously unrecognized mechanism for optimizing antiviral defense and set the stage for the discovery of helicasedependent functions in other Dicers.
D
icer ribonucleases cleave double-stranded RNA (dsRNA) precursors to generate microRNAs (miRNAs) and small interfering RNAs (siRNAs) (1, 2) . In concert with Argonautes, these small RNAs bind complementary mRNAs to down-regulate their expression. miRNAs are processed by Dicer from small hairpins, whereas siRNAs are typically processed from longer dsRNA, from endogenous sources (3), or from exogenous sources such as viral replication intermediates (4) (5) (6) . Some organisms, such as Homo sapiens and Caenorhabditis elegans, encode one Dicer that generates miRNAs and siRNAs, but other organisms have multiple Dicers with specialized functions.
Dicers exist throughout eukaryotes, and a subset have an N-terminal helicase domain of the RIG-I-like receptor (RLR) subgroup (7) (Fig. 1A  and fig. S1A ). RLRs often function in innate immunity (8) , and Dicer helicase domains sometimes show differences in activity that correlate with roles in immunity. For example, Drosophila melanogaster expresses two Dicers, one specialized for processing miRNAs (dmDcr-1) and a second for siRNAs (dmDcr-2) (9). dmDcr-1 has a degenerate helicase domain and is an adenosine triphosphate (ATP)-independent enzyme (10), whereas dmDcr-2, with dedicated antiviral roles (11) (12) (13) , has a conserved helicase domain that hydrolyzes ATP (14) (15) (16) (17) . Under certain conditions, Homo sapiens Dicer-1 (hsDcr-1) also generates viral siRNAs (18, 19) . However, despite conservation of its helicase domain, hsDcr-1 does not hydrolyze ATP in vitro (20) , and its helicase domain is not implicated in viral siRNA biogenesis in vivo (19) . Differences in activities of the helicase domain of vertebrate and invertebrate Dicers may reflect distinct roles in antiviral defense.
dmDcr-2 activity depends on termini of its dsRNA substrates (15, 16) . Blunt (BLT) termini promote a processive reaction whereby multiple siRNAs are produced before dmDcr-2 dissociates, and this reaction requires a functional helicase domain and ATP (15, 17) . In contrast, dsRNAs with 3′ overhanging (3′ovr) termini promote an ATP-independent, distributive cleavage, whereby dmDcr-2 dissociates after each cleavage. hsDcr-1 does not require ATP for processing BLT or 3′ovr termini (fig. S1B, C and D, lanes 5, 7, 10, and 12), suggesting that, at least in vitro, cleavage of BLT dsRNA is not dependent on its helicase domain.
To understand the mechanism of terminus discrimination by dmDcr-2, we used cryo-electron microscopy (cryo-EM) to determine structures of dmDcr-2 alone and in complex with a BLT 52 base pair (bp) dsRNA (52 dsRNA) and ATP-gS (Fig. 1 , figs. S2 to S10, and table S1). We used full-length dmDcr-2 with a point mutation in each ribonuclease III (RNase III) domain to preclude dsRNA cleavage (dmDcr-2 RIII ) (Fig. 1A) . ATP hydrolysis is required for processive cleavage of BLT dsRNA, and dmDcr-2 cannot hydrolyze ATP-gS, which stabilizes a helicase-dependent conformation of dmDcr-2 (16) .
The structure of apo-dmDcr-2 RIII (Fig. 1 , B and C, and figs. S2 to S5) reiterated the "L shape" of lower resolution (~15 to 30 Å) EM reconstructions of hsDcr-1 (21-23). Our 7.1-Å EM density map (Fig. 1B and fig. S2C ) enabled fitting ( fig. S4 , B to F) and homology modeling (Fig. 1B) of Platform-PAZ domains at the cap and tandem RNase III domains in the core. An additional round of three-dimensional (3D) classification ( fig. S3 ) revealed an 8.7-Å map ( fig. S2C ), allowing assignment of the helicase domain at the base (Fig. 1C and fig. S4A ). Fitting of related apohelicases into the EM density is consistent with the helicase domain adopting an open conformation ( fig. S5, A to D) .
The 2D class averages of the dmDcr-2 complex revealed protein with well-resolved secondary structure features bound to the BLT dsRNA terminus ( fig. S6 , B and C). Some protein density was missing, and because control experiments indicated that protein on the grid was intact ( fig.  S7A) , this was likely due to inherent flexibility ( fig. S7B) . Measurements of the dsRNA, guided by major grooves, showed that visible protein footprinted~8 to 9 bps ( fig. S6B ). The crystal structure of RIG-I's helicase domain bound to dsRNA has a similar footprint (24, 25) , suggesting that dmDcr-2's helicase domain bound to BLT dsRNA termini. Indeed, our 6.8-Å reconstruction of the complex (figs. S6E and S8) resembled RIG-I in a closed conformation (Fig. 1D and fig. S9 ). The Hel1 and Hel2 subdomains of RIG-I's helicase, along with the pincer helices ( fig. S1A ), could be fit as a single rigid body ( fig. S9A ). The reconstruction also revealed a helical bundle characteristic of the Hel2i subdomain that could be fitted separately as a rigid body ( fig. S9B ). These fittings enabled a homology model of dmDcr-2's helicase domain bound to BLT dsRNA ( Fig. 1D and fig.  S9 , D and E).
Our models of dmDcr-2's helicase in open (apo) and closed (substrate-bound) conformations implied clamping of the helicase on BLT dsRNA termini ( Fig. 1E and movies S1 and S2). In the open conformation, Hel2 and Hel2i extend away from Hel1, creating a C-shaped opening for substrate engagement (Fig. 1C) . In the BLT dsRNAbound state, Hel2 and Hel2i swivel toward Hel1 to clamp on the terminus (Fig. 1, D and E, and movies S1 and S2).
Within the helicase domain, density was observed for only one RNA strand, indicative of local unwinding (Fig. 1F and fig. S9C ). Unwinding would likely require ATP hydrolysis and possibly was enabled by contaminating ATP in commercial preparations of ATP-gS (16 fig. S11B ; compare lanes 3 and 7, top and bottom panels).
The unwound single strand maintained an A-form conformation (Fig. 1F ), likely to minimize entropic costs of reannealing before cleavage in RNase III sites. Whether the RIG-I helicase unwinds dsRNA is controversial (26, 27) , but related helicases exhibit unwinding activity (28) . Local unwinding may facilitate dmDcr-2's helicase domain in binding and translocating along dsRNA.
The Platform-PAZ domains have been considered the only Dicer domains that bind dsRNA termini (29) (30) (31) (32) , but our structures suggested that the helicase domain also binds termini. To investigate this idea, we purified dmDcr-2 DHel,RIII ( Fig. 2A) , which lacked the helicase domain (Fig. 1A) . Consistent with previous studies (16) , in gel-shift assays full-length dmDcr-2 RIII bound both BLT and 3′ovr dsRNA ( (16, 33) , but strikingly, dmDcr-2
DHel was incapable of cleaving BLT dsRNA (Fig. 2 , E and F; compare lanes 9 and 10). As expected (15, 16) , cleavage of 3′ovr dsRNA was independent of ATP and with both dmDcr-2 WT and dmDcr-2 DHel produced a single siRNA-sized 22-nucleotide (nt) band ( Fig. 2E; compare lanes 7, 8, 11 , and 12). dmDcr-2
DHel cleaved 3′ovr dsRNA more efficiently than dmDcr-2 WT (Fig. 2 , E and F, compare lanes 7, 8, 11, and 12), suggesting that the helicase domain hinders cleavage of 3′ovr dsRNA. This observation is reminiscent of autoinhibition by hsDcr-1's helicase domain in processing 3′ovr dsRNAs (34) .
Our biochemical and structural studies indicated that dmDcr-2 has two modes of substrate recognition and cleavage: one mediated by Platform-PAZ domains and resulting in precise cleavage of 3′ ovr dsRNAs into base-paired 22-nt siRNAs (22mer siRNAs) and a second mediated by the helicase domain and resulting in heterogeneous cleavage of BLT dsRNAs. We searched for amino acids that might separately affect cleavage of a 3′ovr or BLT dsRNA. We created one variant of dmDcr-2 (Fig. 1A, PP) containing five point mutations in the Platform and PAZ domains (35) . Multiple crystal structures show that a phenylalanine in the C-terminal domain (CTD) of RIG-I recognizes BLT dsRNA by stacking on the terminal base pair (24) . Dicer enzymes do not have a CTD, but for the second variant we searched for regions in dmDcr-2 with sequence similarity to the CTD. Within the region identified ( fig. S13 , A to C), we mutated a single phenylalanine to a glycine (dmDcr-2 F225G ). We compared activities of purified dmDcr-2 PP and dmDcr-2 F225G ( fig. S13D ) to dmDcr-2 WT using single-turnover cleavage assays (Fig. 3, A and B) . As expected, cleavage of BLT dsRNA was not observed without ATP (Fig. 3, A and B, lanes 5 to 7). However, with ATP, cleavage of BLT dsRNA by dmDcr-2 WT or dmDcr-2 PP appeared nearly identical (Fig. 3, A and B, lanes 11 and 13), whereas cleavage was completely disrupted by the helicase point mutation in dmDcr-2 F225G (Fig. 3 , A and B, lane 12). [At least part of this effect is due to weakened BLT dsRNA binding ( fig. S13 , E and F, and table S2)]. By contrast, cleavage of 3′ovr dsRNA was independent of ATP and minimally affected by the F225G helicase mutation (Fig. 3,  A and B, lanes 8, 9, 14, and 15) . However, cleavage was eliminated by mutations in the Platform-PAZ domains (Fig. 3, A and B, lanes 10 and 16) . These data reiterate that cleavage of 3′ovr dsRNA is mediated by Platform-PAZ domains, whereas the helicase domain coordinates recognition and cleavage of BLT dsRNA.
While dmDcr-2 PP cleaved BLT dsRNA to yield a pattern nearly identical to dmDcr-2 WT , levels of 22 nt siRNA decreased (Fig. 3, A and B, lanes 11  and 13) . Because 22-nt siRNA was not observed with dmDcr-2 F225G (Fig. 3A, lane 12) , we hypothesized that this species derived from dsRNA that was threaded through the helicase domain until the BLT terminus encountered the Platform-PAZ domains. To confirm that smaller products (<22 nt) did not result from degradation of 22-nt siRNA, we monitored cleavage of chimeric dsRNAs containing deoxynucleotides at positions 21 to 23 from the 5′ terminus (Fig. 3C) . Cleavage of 3′ovr dsRNA was eliminated with chimeric molecules (Fig. 3, D and E; compare lanes 8, 9, 15, and 16) , as expected for Platform-PAZ-mediated cleavage. However, for BLT dsRNA, while 22-nt siRNA was absent, all other fragments were visible (Fig. 3, D and E; compare lanes 6 and 13), consistent with a helicase-mediated threading mechanism.
Studies of Dicer from other organisms indicate Platform-PAZ domains bind termini of 3′ovr dsRNA to allow measuring to RNase III active sites and production of an siRNA length (29, 30) . Our cryo-EM structure of the dmDcr-2 complex and subsequent biochemical studies suggested that BLT dsRNA is cleaved differently, and in an ATP-dependent manner, threaded through the helicase domain to encounter the RNase III active sites. We tested the threading model by designing dsRNA with blocks at specific positions (Fig. 4A) . Measurements using our EM density maps predicted that BLT dsRNAs are threaded through the helicase domain~20 bp before encountering RNase III domains. To trap threading intermediates, we put biotin-dT analogs on both strands of 52 BLT dsRNA, at positions 28 or 37, counting from the 5′ end of the sense strand (Fig.  4A) ; there was no significant difference in cleavage of these modified dsRNAs (figs. S14, A and B). However, we hypothesized that the addition of streptavidin to biotin-dT-substituted dsRNAs (Block dsRNAs) would arrest threading of dsRNAs through the helicase. When dsRNA was incubated with streptavidin before initiating cleavage with dmDcr-2 WT and ATP, we trapped early (<11 nt, Block-28) and intermediate (11 to 20 nt, Block-37) threading products without observing 22 nt siRNAs (Fig. 4, B and C; see fig. S14C for schematic). By contrast, cleavage by hsDcr-1 was unaffected by blocks, indicating that, at least under these conditions, hsDcr-1 cannot thread dsRNA through its helicase domain ( Fig. 4D; compare  lanes 12 to 14 with lanes 15 to 17) .
We anticipated that short threading intermediates (<22 nts) might be unique to the initial cleavage event. However, threading intermediates were observed with dmDcr-2 WT under multipleturnover conditions using internally 32 P-labeled dsRNAs, increasing proportionally with 22mer siRNAs through the reaction time course (fig.  S14, D and E) . Thus, at least in vitro, threading intermediates are recurring by-products of processive cleavage and not specific to the initial cleavage. dmDcr-2's highly efficient, helicase-dependent, processive cleavage is likely advantageous in antiviral defense. The generation of heterogeneous cleavage products during processive cleavage is predicted to dampen the phasing signal of viral siRNAs and is consistent with the overlapping Sinha and percent siRNAs (21 to 23 nt products) resulting from first cleavage were quantified. Data points, mean ± SD (n = 3). *P < 0.05; **P < 0.01; ***P < 0.001.
dmDcr-2
ΔHel,RIII and discontinuous viral siRNAs observed in invertebrate cells (6, 13, 36) . The dsRNA binding protein (dsRBP) Loquacious-PD (Loqs-PD) allows dmDcr-2 to cleave independent of termini (16, 37) and is required for processing endogenous siRNAs (38) , but not for an antiviral response (13) . This suggests that dmDcr-2's intrinsic termini preferences function in viral defense, whereas Loqs-PD allows processing of endogenous dsRNA with diverse termini.
By monitoring cleavage of dsRNAs with 5′ovr termini, or overhangs on both strands ( fig. S15) , we determined that dsRNA with an accessible 3′ terminus is preferentially recognized by the Platform-PAZ domain and, without this feature, is processed by threading through the helicase domain.
RIG-I distinguishes capped termini of cellular transcripts from tri-and diphosphorylated termini of viral transcripts, and this is inferred to allow self versus nonself discrimination (8) . We found that, like RIG-I, dmDcr-2 cannot efficiently process dsRNAs capped at the 5′ terminus, although the phosphorylation state does not affect cleavage ( fig. S16, A and B, and table S3 ). These results may reflect dmDcr-2's ability to process precursors of both endogenous and viral siRNAs.
We show that dmDcr-2 has two modes of cleavage ( Fig. 4E and movies S3 and S4 ). dmDcr-2 is capable of using its Platform-PAZ domain to , and dmDcr-2 PP (30 nM), ±5 mM ATP (n = 3). Substrates were as described in Fig. 2, B and E. AH, arrow, as in Fig. 2E. (B) Quantification of cleavage assays, as in (A). Data points, mean ± SD (n = 3). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; P > 0.05, n.s. recognize 3′ovr dsRNAs in vitro, but it is unknown whether dmDcr-2 processes such dsRNAs in vivo. dmDcr-2's cognate dsRBP, R2D2, may inhibit recognition and processing of substrates with 3′ovr termini (17) . As such, the Platform-PAZ domains of dmDcr-2 may function solely on dsRNAs that are threaded through the helicase domain. At least in vitro, hsDcr-1 does not distinguish termini and does not exhibit helicasedependent threading. Unlike dmDcr-2, hsDcr-1 may rely on the Platform-PAZ domain for generating viral siRNAs. Indeed, mutations to the Platform-PAZ domains of hsDcr-1 disrupt viral siRNA biogenesis (19) . However, given the conservation of hsDcr-1's helicase domain, it is intriguing to consider that, under certain conditions, perhaps with additional factors, hsDcr-1 might mediate processive cleavage by threading of dsRNA through the helicase domain. 
